The Genetic Polymorphisms of NLRP3 Inflammasome Associated with T Helper Cells in Patients with Multiple Myeloma

about

The Genetic Polymorphisms of NLRP3 Inflammasome Associated with T Helper Cells in Patients with Multiple Myeloma

Item

http://www.wikidata.org/entity/Q58711615

description

scientific article published on 23 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

The Genetic Polymorphisms of N ...... Patients with Multiple Myeloma

@en

The Genetic Polymorphisms of N ...... Patients with Multiple Myeloma

@nl

type

Item

label

The Genetic Polymorphisms of N ...... Patients with Multiple Myeloma

@en

The Genetic Polymorphisms of N ...... Patients with Multiple Myeloma

@nl

prefLabel

The Genetic Polymorphisms of N ...... Patients with Multiple Myeloma

@en

The Genetic Polymorphisms of N ...... Patients with Multiple Myeloma

@nl

P1476

The Genetic Polymorphisms of N ...... Patients with Multiple Myeloma

@en

P2093

Chaoqin Zhong

http://www.w3.org/2001/XMLSchema#string

Chen Zhang

http://www.w3.org/2001/XMLSchema#string

Fengjiao Han

http://www.w3.org/2001/XMLSchema#string

Jie Yu

http://www.w3.org/2001/XMLSchema#string

Ming Hou

http://www.w3.org/2001/XMLSchema#string

Mingqiang Hua

http://www.w3.org/2001/XMLSchema#string

Ruiqing Wang

http://www.w3.org/2001/XMLSchema#string

Shuxin Yan

http://www.w3.org/2001/XMLSchema#string

Xueyun Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

The receptor NLRP3 is a transcriptional regulator of TH2 differentiation

Anti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasome

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma

CARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosis.

NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases.

Cytokine gene polymorphisms support diagnostic monitoring of Romanian multiple myeloma patients.

Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers.

P304

7569809

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/7569809

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Daoxin Ma

P577

2018-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30211233

http://www.w3.org/2001/XMLSchema#string

P921

immunology

inflammasome

P932

6126087

http://www.w3.org/2001/XMLSchema#string